MedaSorb Technologies Draws Closer to Completion of Human Clinical Trials

Published: Oct 19, 2009

NEW YORK--(BUSINESS WIRE), the news and research portal for the serious bio-tech investor in conjunction with the Farseers Group is proud to profile one of the most exciting up and coming biotech companies, MedaSorb Technologies (MSBT.OB), which is perfectly poised to realize exponential growth.

Back to news